Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cue Biopharma (CUE) Other financing activities (2017 - 2022)

Historic Other financing activities for Cue Biopharma (CUE) over the last 3 years, with Q4 2022 value amounting to -$1000.0.

  • Cue Biopharma's Other financing activities changed N/A to -$1000.0 in Q4 2022 from the same period last year, while for Sep 2023 it was -$1000.0, marking a year-over-year decrease of 10070.42%. This contributed to the annual value of $141000.0 for FY2022, which is N/A changed from last year.
  • Per Cue Biopharma's latest filing, its Other financing activities stood at -$1000.0 for Q4 2022.
  • Cue Biopharma's Other financing activities' 5-year high stood at $509000.0 during Q2 2018, with a 5-year trough of -$1.1 million in Q1 2018.